This CME program provides a comprehensive and up-to-date perspective on the evolving management of patients with inflammatory bowel disease (IBD). We will be discussing unmet needs in the current identification and management of IBD; identifying tools to assist with differential diagnosis, clinical assessment, and selection of effective therapies for IBD; and exploring the underlying pathophysiology of IBD and the role of JAK inhibition in modifying therapeutic outcomes.

RELEASE DATE: September 20, 2022

EXPIRATION DATE: September 20, 2023

This innovative online activity will evaluate the importance of targeting JAK/STAT signaling in IBD from a pathophysiologic perspective and the role of JAK inhibition in modifying therapeutic outcomes. Learn more about key unmet needs in IBD and the relevance of novel therapy in clinical management, as well as about current perspectives in differential diagnosis, clinical assessment and the appropriate choice of effective therapy in IBD management.

RELEASED DATE: October 23, 2023

EXPIRATION DATE: October 23, 2024